View of MEASUREMENT OF INTRAOCULAR PRESSURE FOLLOWING 0.05 ML (1.25MG) INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) TO DETERMINE THE RATIONALE OF USING POST-INJECTION IOP LOWERING MEDICATION

Return to Article Details MEASUREMENT OF INTRAOCULAR PRESSURE FOLLOWING 0.05 ML (1.25MG) INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) TO DETERMINE THE RATIONALE OF USING POST-INJECTION IOP LOWERING MEDICATION Download Download PDF